Regulatory T cells ameliorate BBB damage after cerebral ischemia [67] as well as hemorrhagic transformation after tPA administration following ischemic stroke in part by inhibiting CCL2 (monocyte chemoattractant protein 1) and MMP9 [68]. The gene discussed is PLAT; the disease is Cerebral ischemia.